The effects of oral rabeprazole on endocrine and gastric secretory function ill healthy volunteers

Citation
Hg. Dammann et al., The effects of oral rabeprazole on endocrine and gastric secretory function ill healthy volunteers, ALIM PHARM, 13(9), 1999, pp. 1195-1203
Citations number
24
Categorie Soggetti
Pharmacology,"da verificare
Journal title
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
ISSN journal
02692813 → ACNP
Volume
13
Issue
9
Year of publication
1999
Pages
1195 - 1203
Database
ISI
SICI code
0269-2813(199909)13:9<1195:TEOORO>2.0.ZU;2-9
Abstract
Aim: To evaluate the short-term effects of rabeprazole 20 mg on endocrine p arameters, in particular serum testosterone and cortisol, and on 24 h intra gastric pH, H+ activity and nocturnal gastric acid secretion. Methods: In this double-blind, two-period crossover study, 12 healthy young male volunteers were randomly given oral rabeprazole 20 mg o.m. or placebo for 14 days, There was a washout period of tit least 1 week between the tw o studies, The effects of rabeprazole and placebo on cortisol and testoster one (primary criteria), and on tri-iodothyronine, thyroxine, 17 beta-oestra diol, thyroid-stimulating hormone, thyroxine-binding protein, parathyroid h ormone, insulin, glucagon, rennin, aldosterone, follicle-stimulating hormon e, luteotrophic hormone, prolactin, somatotrophic hormone, dehydroepiandros terone. cortisol-binding globulin and urinary 6-beta hydroxycortisol were c ompared. Intragastric 24 h pH, 24 h H+ activity and nocturnal gastric acid secretion were determined by pH probe and gastric aspiration. Results: Rabeprazole produced no clinically relevant effects on endocrine f unction as assessed by measure-ment of serum testosterone, circadian serum cortisol levels, ACTH-stimulated serum cortisol levels and 17 other endocri ne function tests. Rabeprazole significantly increased the 24 h median pH v alues compared to placebo (on Days 7 and 14 median values ranged from 3.92 to 6.88 with rabeprazole and from 1.48 and 4.22 with placebo, P < 0.001) an d significantly decreased the integrated 24 h H+ activity (AUC(08-08)) from 343 mmol/L/h with placebo to 44 mmol/L/h with rabeprazole (P < 0.001). Fol lowing cessation of dosing, intragastric pH levels decreased and H+ activit y increased, but acid secretion did not recover completely during the next 72 h. The mean value for nocturnal gastric acid secretion on Days 7 and 8 w as 36 mmol/6 h with placebo and 5.6 mmol/6 h with rabeprazole (P < 0.001), Rabeprazole was well tolerated. Conclusion: Rabeprazole did not influence endocrine function in healthy you ng male volunteers during short-term dosing, Rabeprazole substantially incr eased intragastric pH over a 24 h period and significantly decreased intrag astric acidity and nocturnal gastric acid secretion.